| Dr Elvis Boamah, PHARMD | |
|
2419 Nichol Ave, Anderson, IN 46016-3070 | |
| (765) 643-4313 | |
| Not Available |
| Full Name | Dr Elvis Boamah |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2419 Nichol Ave, Anderson, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346844412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26026997A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Elvis Boamah, PHARMD 2419 Nichol Ave, Anderson, IN 46016-3070 Ph: (765) 643-4313 | Dr Elvis Boamah, PHARMD 2419 Nichol Ave, Anderson, IN 46016-3070 Ph: (765) 643-4313 |
News Archive
November ushers in American Diabetes Month - not only a time to be thankful for bustling basic and clinical research underway on the disease, but also the unofficial start of the holiday season.
Gilead Sciences, Inc. today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for marketing approval for the fixed-dose combination of Truvada® (emtricitabine and tenofovir disoproxil (as fumarate)) and Tibotec Pharmaceuticals' investigational non-nucleoside reverse transcriptase inhibitor TMC278 (rilpivirine (as hydrochloride)) for the treatment of HIV-1 infection in adults.
Olympus, a leading manufacturer of high-end research microscopes, and Cytosurge, a precision manufacturer of cell manipulation technologies, have entered a co-marketing agreement to become a complete system provider to the scientific community's growing need for next-generation single-cell and CRISPR genetic manipulation solutions.
A promising new therapy for the most common form of lung cancer appears to produce largely manageable side effects, and an ongoing clinical trial is determining whether the compound treats tumors more effectively than what's on the market, according research that scientists at Fox Chase Cancer Center will present at the 49th Annual Meeting of the American Society of Clinical Oncology on Saturday, June 1.
The Substance Abuse and Mental Health Services Administration (SAMHSA) is awarding up to $1.5 million, over three years, to Morehouse School of Medicine to enhance the effort to network the 105 Historically Black Colleges and Universities throughout the United States to promote behavioral health, expand campus service capacity and facilitate workforce development.
› Verified 7 days ago
Lynette Sullivan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Broadway St, Anderson, IN 46012 Phone: 765-643-1515 | |
Mr. Willard Grubb, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6610 S Scatterfield Rd, Anderson, IN 46013 Phone: 765-683-5233 Fax: 765-683-5265 | |
Timothy Cosman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2003 Broadway St, Anderson, IN 46012 Phone: 765-643-1515 | |
Vadim Shinkevich, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3824 Main St, Anderson, IN 46013 Phone: 860-989-7520 | |
Reham Nakhla, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-5025 | |
Mr. James C Hoffman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 505 Madison Ave, Anderson, IN 46016 Phone: 765-643-3716 Fax: 765-643-0265 | |
Dr. Francis Oppong-asante, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2321 Charles St, Anderson, IN 46013 Phone: 765-642-5365 Fax: 765-683-9105 |